Aug 01, 2025 20:55
XENE - Xenon Pharmaceuticals Inc
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 40.2 0.87 (2.16%) | --- | -0.08 (-0.18%) | 0.0 (0.0%) | 0.1 (0.25%) | 0.95 (2.37%) | --- | 0.1 (0.25%) |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -1.07
- Diluted EPS:
- -1.07
- Basic P/E:
- -38.3832
- Diluted P/E:
- -38.3832
- RSI(14) 1m:
- 48.84
- VWAP:
- 41.09
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
May 02, 2025 20:42
Feb 20, 2025 18:00
Jul 02, 2024 13:22
May 28, 2024 12:30
May 10, 2024 12:17
May 09, 2024 20:01
May 08, 2024 20:01
May 07, 2024 20:01
May 06, 2024 16:00